{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:30:09Z","timestamp":1769862609960,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.transproceed.2023.02.047","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T16:04:07Z","timestamp":1680278647000},"page":"606-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elevated Alfa-Fetoprotein and Des-Gamma-Carboxy Prothrombin Levels Predict Poor Outcomes After Liver Transplantation for Hepatocellular Carcinoma Beyond the Japan Criteria"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7081-7679","authenticated-orcid":false,"given":"Masatsugu","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Shimata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Hirukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Isono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.02.047_bib0001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/tri.13391","article-title":"Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study","volume":"32","author":"Shimamura","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0003","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jso.21786","article-title":"Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma","volume":"103","author":"Chun","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/tri.12274","article-title":"Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma","volume":"27","author":"Shindoh","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/lt.20140","article-title":"Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome","volume":"10","author":"Shetty","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0006","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO;2-0","article-title":"How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system","volume":"89","author":"Farinati","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0007","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1053\/jhep.2001.29202","article-title":"Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma","volume":"34","author":"Fujioka","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0008","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3748\/wjg.14.1370","article-title":"Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma","volume":"14","author":"Hakamada","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0009","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cncr.24031","article-title":"High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma","volume":"115","author":"Kobayashi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000106908","article-title":"Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria","volume":"25","author":"Takada","year":"2007","journal-title":"Dig Dis"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0011","doi-asserted-by":"crossref","first-page":"E491","DOI":"10.1111\/j.1399-0012.2011.01463.x","article-title":"Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation","volume":"25","author":"Shirabe","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0012","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2014.11.005","article-title":"Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion","volume":"62","author":"Pot\u00e9","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00595-011-0058-8","article-title":"Role of tumor-associated macrophages in the progression of hepatocellular carcinoma","volume":"42","author":"Shirabe","year":"2012","journal-title":"Surg Today"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/tri.12191","article-title":"Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer","volume":"27","author":"Lai","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0015","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/lt.25204","article-title":"Lymphocyte-to-monocyte ratio is a predictor of survival after liver transplantation for hepatocellular carcinoma","volume":"24","author":"Mano","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0016","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/TP.0000000000003246","article-title":"Impact of donor age on the outcome of living-donor liver transplantation: special consideration to the feasibility of using elderly donors","volume":"105","author":"Kadohisa","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0018","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/lt.25977","article-title":"Portal vein complications after adult living donor liver transplantation: time of onset and deformity patterns affect long-term outcomes","volume":"27","author":"Sambommatsu","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0019","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1097\/TXD.0000000000000780","article-title":"Adult living donor liver transplantation for patients with portal vein thrombosis: a single-center experience","volume":"4","author":"Miura","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/TP.0b013e31821dcae3","article-title":"Cyclosporine A-based immunotherapy in adult living donor liver transplantation: accurate and improved therapeutic drug monitoring by 4-hr intravenous infusion","volume":"92","author":"Hibi","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0021","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000137129.98894.42","article-title":"Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan","volume":"240","author":"Todo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0022","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria","volume":"61","author":"Yao","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0023","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2017.11.037","article-title":"Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within milan criteria: a multicenter study","volume":"16","author":"Mehta","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0024","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0025","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0026","doi-asserted-by":"crossref","first-page":"15855","DOI":"10.1038\/s41598-019-52427-8","article-title":"Prediction of early recurrence of solitary hepatocellular carcinoma after orthotopic liver transplantation","volume":"9","author":"Feng","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0027","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0028","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.transproceed.2023.02.047_bib0029","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.29904","article-title":"Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification","volume":"68","author":"Kurebayashi","year":"2018","journal-title":"Hepatology"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523001185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523001185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:45:34Z","timestamp":1758577534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134523001185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0041134523001185"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.02.047","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Alfa-Fetoprotein and Des-Gamma-Carboxy Prothrombin Levels Predict Poor Outcomes After Liver Transplantation for Hepatocellular Carcinoma Beyond the Japan Criteria","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}